A major scientific advance in protein modeling developed by Microsoft Research AI for Science, has been published in Science.

AI meets molecular dynamics in Divamics’ latest breakthroughs, accelerating new therapies for complex metabolic conditions.

Microsoft's CEO, Satya Nadella, has announced BioEmu-1, a new AI system designed to accelerate drug discovery by decoding ...

Conversations with entrepreneurs, technologists, and researchers on emerging technologies and the importance of STEM in drug discovery.

While AI-driven approaches tout increased speed and lower costs, commercial interests compromise scientific collaboration.

Satya Nadella has unveiled BioEmu, Microsoft's new AI initiative aimed at accelerating drug discovery processes.

Learn how AI and machine learning enhance antibody discovery – from structure prediction to binding optimization – with ...

Using an AI-driven drug discovery process, the drug known as vorinostat was identified as a promising treatment for Rett ...

Drug discovery startup Synfini Inc. said today it has closed on an $8.9 million expansion funding round led by JSL Health ...

Microsoft’s new AI system BioEmu will help decode protein motion and help in faster discovery of drugs, said CEO Satya ...

UC Santa Barbara researchers and collaborators from campus biotech spinoff Integrated Biosciences, as well as Harvard, MIT ...

A new drug targets RAS-PI3Kα pathways without harmful side effects. It was developed using high-performance computing and AI.